高榕创投
@gaorong
创造美好生活
Articles
"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
Hangzhou Andao Pharma Closes $50 Million Series B to Advance Drug Development for Kidney Disease and Cancer
Addressing the enormous unmet clinical needs in nephrology and oncology.
Unknown Closes Nearly $100 Million in Series B Funding, Launches AI×BT Strategy
Focused on gut microbiome AI-driven drug discovery, with self-developed drug candidates already in registrational clinical trials.
Chuanwazi Foods Raises Nearly RMB 300 Million in Series A Funding, Aiming to Become China's Go-To Brand for Fresh Sauce
Bold and zesty, there for every meal.
Chao Wan Zu (潮玩族) Completes Series B Funding Round, Building a Community for Young Collectors
China's largest secondhand designer toy trading platform and community.
When Will We Achieve "Genomic Sequencing Freedom"? | Gaorong Ventures "Future"
A Conversation with the Creator of China's First Mass-Produced Nanopore Gene Sequencer
Rongbao · November | New milestones for drug R&D, chips, and autonomous driving; UJU Media lists on Hong Kong Stock Exchange Main Board
New funding, new products, new applications.
Raysolve Closes Pre-A Round, Full-Color Micro-LED Micro-Display Chips to Power Consumer AR Applications
This round was led by Gaorong Ventures.
The Beijing Stock Exchange Sets Sail: A Rational IPO Planning Guide for Startups | Ronghui Practical Insights
CITIC Securities Construction Li Xudong: Key Highlights of the Beijing Stock Exchange Regulatory Framework
Xinhuazhang Unveils Major Digital Verification EDA Product! Endgame Thinking to Boost Chip Design Efficiency
Xinhuazhang's Wang Libin: Giving the Chip Industry "A Winning Hand, Validation Freedom"